These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
695 related articles for article (PubMed ID: 14715868)
1. Phosphodiesterase 4 inhibition synergizes with relaxin signaling to promote decidualization of human endometrial stromal cells. Bartsch O; Bartlick B; Ivell R J Clin Endocrinol Metab; 2004 Jan; 89(1):324-34. PubMed ID: 14715868 [TBL] [Abstract][Full Text] [Related]
2. Relaxin and phosphodiesterases collaborate during decidualization. Bartscha O; Ivell R Ann N Y Acad Sci; 2004 Dec; 1030():479-92. PubMed ID: 15659833 [TBL] [Abstract][Full Text] [Related]
3. Progesterone-dependent decidualization of the human endometrium is mediated by cAMP. Brar AK; Frank GR; Kessler CA; Cedars MI; Handwerger S Endocrine; 1997 Jun; 6(3):301-7. PubMed ID: 9368687 [TBL] [Abstract][Full Text] [Related]
4. Activated protein kinase A is required for differentiation-dependent transcription of the decidual prolactin gene in human endometrial stromal cells. Telgmann R; Maronde E; Taskén K; Gellersen B Endocrinology; 1997 Mar; 138(3):929-37. PubMed ID: 9048592 [TBL] [Abstract][Full Text] [Related]
5. Relaxin and prostaglandin E(2) regulate interleukin 11 during human endometrial stromal cell decidualization. Dimitriadis E; Stoikos C; Baca M; Fairlie WD; McCoubrie JE; Salamonsen LA J Clin Endocrinol Metab; 2005 Jun; 90(6):3458-65. PubMed ID: 15784719 [TBL] [Abstract][Full Text] [Related]
6. Comparative studies on the in vitro decidualization process in the baboon (Papio anubis) and human. Kim JJ; Jaffe RC; Fazleabas AT Biol Reprod; 1998 Jul; 59(1):160-8. PubMed ID: 9675007 [TBL] [Abstract][Full Text] [Related]
7. Ligand activated relaxin receptor increases the transcription of IGFBP-1 and prolactin in human decidual and endometrial stromal cells. Tang M; Mazella J; Zhu HH; Tseng L Mol Hum Reprod; 2005 Apr; 11(4):237-43. PubMed ID: 15722441 [TBL] [Abstract][Full Text] [Related]
8. Endometrial stromal cells undergoing decidualization down-regulate their properties to produce proinflammatory cytokines in response to interleukin-1 beta via reduced p38 mitogen-activated protein kinase phosphorylation. Yoshino O; Osuga Y; Hirota Y; Koga K; Hirata T; Yano T; Ayabe T; Tsutsumi O; Taketani Y J Clin Endocrinol Metab; 2003 May; 88(5):2236-41. PubMed ID: 12727980 [TBL] [Abstract][Full Text] [Related]
9. KF19514, a phosphodiesterase 4 and 1 inhibitor, inhibits TNF-alpha-induced GM-CSF production by a human bronchial epithelial cell line via inhibition of PDE4. Sasaki K; Manabe H Inflamm Res; 2004 Jan; 53(1):31-7. PubMed ID: 15021978 [TBL] [Abstract][Full Text] [Related]
10. Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element-binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells. MacKenzie SJ; Houslay MD Biochem J; 2000 Apr; 347(Pt 2):571-8. PubMed ID: 10749688 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia. Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681 [TBL] [Abstract][Full Text] [Related]
12. Type IV phosphodiesterase activity specifically regulates cAMP-stimulated casein secretion in the rat mammary gland. Pooley L Biochim Biophys Acta; 2002 Jun; 1590(1-3):84-92. PubMed ID: 12063171 [TBL] [Abstract][Full Text] [Related]
13. beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi. Baillie GS; Sood A; McPhee I; Gall I; Perry SJ; Lefkowitz RJ; Houslay MD Proc Natl Acad Sci U S A; 2003 Feb; 100(3):940-5. PubMed ID: 12552097 [TBL] [Abstract][Full Text] [Related]
14. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation. Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238 [TBL] [Abstract][Full Text] [Related]
15. Selective up-regulation of phosphodiesterase-4 cyclic adenosine 3',5'-monophosphate (cAMP)-specific phosphodiesterase variants by elevated cAMP content in human myometrial cells in culture. Méhats C; Tanguy G; Dallot E; Robert B; Rebourcet R; Ferré F; Leroy MJ Endocrinology; 1999 Jul; 140(7):3228-37. PubMed ID: 10385419 [TBL] [Abstract][Full Text] [Related]
16. Phospholipase D1 as a key enzyme for decidualization in human endometrial stromal cells. Yoon MS; Koo JB; Jeong YG; Kim YS; Lee JH; Yun HJ; Lee KS; Han JS Biol Reprod; 2007 Feb; 76(2):250-8. PubMed ID: 17065600 [TBL] [Abstract][Full Text] [Related]
17. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis. Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454 [TBL] [Abstract][Full Text] [Related]
18. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells. Verghese MW; McConnell RT; Lenhard JM; Hamacher L; Jin SL Mol Pharmacol; 1995 Jun; 47(6):1164-71. PubMed ID: 7603456 [TBL] [Abstract][Full Text] [Related]
19. Cyclic nucleotide phosphodiesterases (PDE) 3 and 4 in normal, malignant, and HTLV-I transformed human lymphocytes. Ekholm D; Mulloy JC; Gao G; Degerman E; Franchini G; Manganiello VC Biochem Pharmacol; 1999 Sep; 58(6):935-50. PubMed ID: 10509746 [TBL] [Abstract][Full Text] [Related]
20. Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4). Thompson WJ; Ashikaga T; Kelly JJ; Liu L; Zhu B; Vemavarapu L; Strada SJ Biochem Pharmacol; 2002 Feb; 63(4):797-807. PubMed ID: 11992650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]